These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25560487)

  • 1. CIP2A mediates prostate cancer progression via the c-MYC signaling pathway.
    Guo Z; Liu D; Su Z
    Tumour Biol; 2015 May; 36(5):3583-9. PubMed ID: 25560487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
    Guo Z; Liu D; Su Z
    Tumour Biol; 2015 Jun; 36(6):4777-83. PubMed ID: 25636449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CC-chemokine receptor 7 is overexpressed and correlates with growth and metastasis in prostate cancer.
    Chen Y; Tian Y; Ji Z; Liu Z; Shang D
    Tumour Biol; 2015 Jul; 36(7):5537-41. PubMed ID: 25682287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.
    Liu N; He QM; Chen JW; Li YQ; Xu YF; Ren XY; Sun Y; Mai HQ; Shao JY; Jia WH; Kang TB; Zeng MS; Ma J
    Mol Cancer; 2014 May; 13():111. PubMed ID: 24884612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion.
    Zhai M; Cong L; Han Y; Tu G
    Tumour Biol; 2014 Feb; 35(2):1123-8. PubMed ID: 24014087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of CCL19/CCR7 on the proliferation and migration of cell in prostate cancer.
    Peng C; Zhou K; An S; Yang J
    Tumour Biol; 2015 Jan; 36(1):329-35. PubMed ID: 25256673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celastrol inhibits chondrosarcoma proliferation, migration and invasion through suppression CIP2A/c-MYC signaling pathway.
    Wu J; Ding M; Mao N; Wu Y; Wang C; Yuan J; Miao X; Li J; Shi Z
    J Pharmacol Sci; 2017 May; 134(1):22-28. PubMed ID: 28522217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.
    Khanna A; Böckelman C; Hemmes A; Junttila MR; Wiksten JP; Lundin M; Junnila S; Murphy DJ; Evan GI; Haglund C; Westermarck J; Ristimäki A
    J Natl Cancer Inst; 2009 Jun; 101(11):793-805. PubMed ID: 19470954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis.
    Dong QZ; Wang Y; Dong XJ; Li ZX; Tang ZP; Cui QZ; Wang EH
    Ann Surg Oncol; 2011 Mar; 18(3):857-65. PubMed ID: 20842459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CIP2A regulates proliferation and apoptosis of multiple myeloma cells.
    Zheng Z; Qiao Z; Chen W; Gong R; Wang Y; Xu L; Ma Y; Zhang L; Lu Y; Jiang B; Li G; Dong C
    Mol Med Rep; 2016 Sep; 14(3):2705-9. PubMed ID: 27484817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells.
    Pallai R; Bhaskar A; Barnett-Bernodat N; Gallo-Ebert C; Pusey M; Nickels JT; Rice LM
    Tumour Biol; 2015 Aug; 36(8):6383-90. PubMed ID: 25833693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize metastatic castration-resistant prostate cancer cells to cabazitaxel chemotherapy.
    Huang J; Jia J; Tong Q; Liu J; Qiu J; Sun R; Yao L; Yang C
    Tumour Biol; 2015 Mar; 36(3):1589-94. PubMed ID: 25377160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions.
    Jung HM; Patel RS; Phillips BL; Wang H; Cohen DM; Reinhold WC; Chang LJ; Yang LJ; Chan EK
    Mol Biol Cell; 2013 Jun; 24(11):1638-48, S1-7. PubMed ID: 23552692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes.
    Niemelä M; Kauko O; Sihto H; Mpindi JP; Nicorici D; Pernilä P; Kallioniemi OP; Joensuu H; Hautaniemi S; Westermarck J
    Oncogene; 2012 Sep; 31(39):4266-78. PubMed ID: 22249265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer.
    Wang X; Shi Z; Liu X; Su Y; Li W; Dong H; Zhao L; Li M; Wang Y; Jin X; Huo Z
    J BUON; 2018; 23(2):444-452. PubMed ID: 29745091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CIP2A influences survival in colon cancer and is critical for maintaining Myc expression.
    Wiegering A; Pfann C; Uthe FW; Otto C; Rycak L; Mäder U; Gasser M; Waaga-Gasser AM; Eilers M; Germer CT
    PLoS One; 2013; 8(10):e75292. PubMed ID: 24098375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIP2A, an oncoprotein, is associated with cell proliferation, invasion and migration in laryngeal carcinoma cells.
    Chen XD; Tang SX; Zhang JH; Zhang LT; Wang YW
    Oncol Rep; 2017 Aug; 38(2):1005-1012. PubMed ID: 28656258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pin1 promotes prostate cancer cell proliferation and migration through activation of Wnt/β-catenin signaling.
    Zhu Z; Zhang H; Lang F; Liu G; Gao D; Li B; Liu Y
    Clin Transl Oncol; 2016 Aug; 18(8):792-7. PubMed ID: 26497355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CIP2A is associated with human breast cancer aggressivity.
    Côme C; Laine A; Chanrion M; Edgren H; Mattila E; Liu X; Jonkers J; Ivaska J; Isola J; Darbon JM; Kallioniemi O; Thézenas S; Westermarck J
    Clin Cancer Res; 2009 Aug; 15(16):5092-100. PubMed ID: 19671842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancerous inhibitor of protein phosphatase 2A promotes premature chromosome segregation and aneuploidy in prostate cancer cells through association with shugoshin.
    Pallai R; Bhaskar A; Barnett-Bernodat N; Gallo-Ebert C; Nickels JT; Rice LM
    Tumour Biol; 2015 Aug; 36(8):6067-74. PubMed ID: 25736928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.